DERM News and Press, Journey Medical Corporation

2026-05-29 17:20:13 ET Read the full article on Seeking Alpha For further details see: Fortress Biotech: Is It Time To Pay The Deferred Preferred Stock Dividends?

SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-appr...

2026-05-13 19:32:15 ET More on Journey Medical Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript Journey Medical targets expanded Emrosi coverage and EBITDA growth through 2026 amid...

2026-05-13 19:30:47 ET Journey Medical Corporation (DERM) Q1 2026 Earnings Call May 13, 2026 4:30 PM EDT... Read the full article on Seeking Alpha For further details see: Journey Medical Corporation (DERM) Q1 2026 Earnings Call Transcript

2026-05-13 17:55:29 ET Image source: The Motley Fool. May 13, 2026 Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

2026-05-13 16:30:05 ET More on Journey Medical Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript Journey Medical targets expanded Emrosi coverage and EBITDA growth through 2026 amid robust prescription demand Journey Medical Non-GAAP EPS of $0.10, r...

Total revenues for the first quarter ended March 31, 2026 increased 21% year-over-year to $16.0 million  Emrosi ® revenues were $6.3 million in the first quarter ended March 31, 2026 Cash position increased to $27 million, driven by strong financial performance Company to...

SCOTTSDALE, Ariz., May 06, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or the “Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on developing, selling and marketing U.S. Food and Drug Administration (...

SCOTTSDALE, Ariz., April 21, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”, “we”, or “our”), a commercial-stage pharmaceutical company primarily focused on developing, selling and mar...

2026-03-25 22:46:37 ET More on Journey Medical Journey Medical Corporation (DERM) Q4 2025 Earnings Call Transcript Journey Medical: Emrosi Is Winning, But The Stock Hasn't Noticed Journey Medical Non-GAAP EPS of $0.10, revenue of $61.6M misses by $3.05M Seeki...